NS

Neelam Suri

Active Director Director DIN 06924890
DIN 06924890 First appointment Mar 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2014
Shareholding value Locked Premium profile

About Neelam Suri

Neelam Suri has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Clyde Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06924890
Primary Designation Director
First Appointment 10 Mar 2014
Oldest Company Age 14 yrs

Current companies

Company Designation Appointment Founded Status
Clyde Pharmaceutical Private Limited U47721UP2011PTC234959
Director 10 Mar 2014 2011 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Clyde Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Neelam Suri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Suri

Neelam Suri has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Clyde Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Neelam Suri is associated with 1 company as Director.

Neelam Suri has expertise in General Business.

Neelam Suri has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available